milrinone has been researched along with carvedilol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
| Antonio, C; Choudhary, G; Heaney, L; Jain, A; Just, V; Kumar, A; Papp, MA | 1 |
| Bristow, MR; Eichhorn, EJ; Gilbert, EM; Lowes, BD; Tsvetkova, T | 1 |
| Hauptman, PJ; Prirzker, MR; Woods, D | 1 |
| Adams, KF; Felker, GM; Gattis, WA; Gheorghiade, M; Leimberger, JD; O'Connor, CM | 1 |
| Paul, S; Trupp, RJ | 1 |
| Ebisawa, T; Fujimoto, K; Hori, Y; Maekawa, S; Uechi, M; Yamano, S | 1 |
| Earl, GL; Fitzpatrick, JM; Narula, J; Verbos-Kazanas, MA | 1 |
| Ahmad, T; Milano, CA; Patel, CB; Rogers, JG | 1 |
2 review(s) available for milrinone and carvedilol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
3 trial(s) available for milrinone and carvedilol
| Article | Year |
|---|---|
Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Propanolamines; Retrospective Studies | 2001 |
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Milrinone; Propanolamines; Stroke Volume; Treatment Outcome | 2003 |
Cardiovascular effects of a phosphodiesterase III inhibitor in the presence of carvedilol in dogs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Cardiovascular Physiological Phenomena; Carvedilol; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dogs; Dopamine; Drug Interactions; Female; Heart Rate; Male; Milrinone; Myocardial Contraction; Propanolamines | 2006 |
9 other study(ies) available for milrinone and carvedilol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Propanolamines; Prospective Studies; Pulmonary Wedge Pressure; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2001 |
Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiotonic Agents; Carvedilol; Drug Therapy, Combination; Heart Failure; Humans; Infusions, Intravenous; Metoprolol; Milrinone; Propanolamines; Treatment Outcome | 2002 |
Case studies in heart failure.
Topics: Activities of Daily Living; Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiac Catheterization; Cardiotonic Agents; Carvedilol; Diet, Sodium-Restricted; Dyspnea; Echocardiography; Electrocardiography; Fatigue; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Prognosis; Propanolamines; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left | 2003 |
Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Carbazoles; Cardiac Output, Low; Cardiotonic Agents; Carvedilol; Creatinine; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Hospitals, University; Humans; Hypotension; Male; Metoprolol; Middle Aged; Milrinone; Oxygen Consumption; Propanolamines; Retrospective Studies; Sodium; Vasodilator Agents | 2007 |
When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiotonic Agents; Carvedilol; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Furosemide; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Lisinopril; Male; Middle Aged; Milrinone; Propanolamines; Severity of Illness Index; Spironolactone | 2012 |